Dr.Carolyn H.

Mercyhealth Hospital and Physician Clinic–Crystal Lake Pharmacists

Chicago, Illinois, United States

About

BS/BA degree and 5+ years of drug development experience in academia and/or the Biopharmaceutical industry.Experienced in clinical trial methodology.Master's degree and 13+ years of related experience as shown above, PharmD & PhD

Experience

  • Senior Scientist / Principal Scientist - In vitro Pharmacology at FDA
    Jan 2021 - Present · 5 yrs 6 mos

    I make formula for medicine's! I use the growing understanding of biology to identify ‘targets’. A target is a structure – like an enzyme – in the body that contributes to the development of a disease or its symptoms. It is important initially to know that the target we select is valid, and that it affects the disease process in the way that the science suggests. Once a target has been identified, the next step is to find chemicals or natural compounds that might inhibit or enhance the target’s activity. Current techniques allow many hundreds of compounds to be screened for that sort of activity very quickly. Compounds that show the sort of effect we want are called 'hits'. Once a medicine has successfully completed all three phases of clinical trials, the information is submitted to government regulators. This is the formal application to seek approval for the new medicine. The process must be followed in every territory in which I hope to offer the new treatment to doctors and patients.